Peptide carrier fusion proteins as allergy vaccines

US9308251B2 · kind B2 · utility

Assignee

• BIOMAY AG · AT

Inventors

• Katarzyna Niespodziana · Wien, AT
• Margarete Focke-Tejkl · Wien, AT
• Susanne Vrtala · Wien, AT
• Srinita Banerjee · Wien, AT
• Kuan-Wei Chen · Tainan, TW
• Milena Weber · Wien, AT
• Rudolf Valenta · Theresienfeld, AT
• Katharina Marth · Wien, AT

Key dates

• Filing date: Jun 11, 2012
• Grant date: Apr 12, 2016
• Expiry date: Jun 11, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2730/10134
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.